Cargando…
Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury
BACKGROUND: Macrophages persist indefinitely at sites of spinal cord injury (SCI) and contribute to both pathological and reparative processes. While the alternative, anti-inflammatory (M2) phenotype is believed to promote cell protection, regeneration, and plasticity, pro-inflammatory (M1) macropha...
Autores principales: | Zhang, Bei, Bailey, William M., Kopper, Timothy J., Orr, Michael B., Feola, David J., Gensel, John C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657208/ https://www.ncbi.nlm.nih.gov/pubmed/26597676 http://dx.doi.org/10.1186/s12974-015-0440-3 |
Ejemplares similares
-
Delayed Azithromycin Treatment Improves Recovery After Mouse Spinal Cord Injury
por: Kopper, Timothy J., et al.
Publicado: (2019) -
Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment
por: Gensel, John C., et al.
Publicado: (2017) -
Continued development of azithromycin as a neuroprotective therapeutic for the treatment of spinal cord injury and other neurological conditions
por: Kopper, Timothy J., et al.
Publicado: (2020) -
The effects of myelin on macrophage activation are phenotypic specific via cPLA(2) in the context of spinal cord injury inflammation
por: Kopper, Timothy J., et al.
Publicado: (2021) -
Spinal cord contusion
por: Ju, Gong, et al.
Publicado: (2014)